Eight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure. Two participants who discontinued NUC ...

Computer scientists, bioengineers and AI specialists from the Arc Institute and Stanford University have developed an ...

A next-generation metagenomic sequencing test developed at UCSF demonstrates its ability to rapidly and accurately diagnose a ...

Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

To understand the workings of DNA in relation to disease, scientists at Los Alamos National Laboratory have developed the first multimodal deep learning model of its kind, EPBDxDNABERT-2, capable of ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

Well-established techniques rely on making DNA sequences from scratch to create the DNA storage medium. The process known as "de novo" is time-consuming, expensive, and prone to errors. Researchers ...

Direct sequencing-based assays have limited sensitivity ... Commercial assays available for HBV DNA quantitation. Method Commercial kits Lower limit of detection Ref. If ALT becomes persistently ...

When the mRNA is expressed in HBV-infected hepatocytes, it cuts a sequence in the HBV genome that is designed to eliminate cccDNA in vivo. With this approach, the company hopes to stop HBV from ...